Diabetes drug could increase stem cells in the womb to treat recurrent miscarriage
January 9, 2020Business Services Stem cells, diabetes, insulin, miscarraiges, pregnancy
A study led by the University of Warwick found that sitagliptin, a diabetes drug, could be used to treat recurrent …
Largest drop ever in US cancer mortality rates, new study shows
January 9, 2020Business Services Cancer, brain cancer, lung cancer, prostate cancer
The overall cancer mortality rate in the US fell by 2.2% from 2016 to 2017, the largest ever annual decline …
China approves first homegrown HPV vaccine
January 8, 2020Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines
Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
No link between talc and ovarian cancer, new study reveals
January 8, 2020Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder
Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …
Apellis therapy outflanks Alexion’s Soliris in head-to-head paroxysmal nocturnal haemoglobinuria
January 8, 2020Research and Development Alexion, Appelis, pegcetacoplan, pharma, soliris
Apellis Pharmaceuticals has revealed new Phase 3 demonstrating that its targeted C3 inhibitor pegcetacoplan met its primary endpoint and outclassed …
Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis
January 8, 2020Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids
Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …
FDA approves alternative approach for Abbot HeartMate 3 heart pump
January 8, 2020Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease
The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …
Saniona appoints Rami Levin as President and Chief Executive Officer
January 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, rare diseases
Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks …
FibroGen names Lilly veteran as new CEO
January 7, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, fibrogen, pharma
Eli Lilly veteran Enrique Conterno has been revealed as the new Chief Executive Officer of FibroGen following the unexpected death …
FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload
January 7, 2020Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma
Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …
Bavencio extends survival at Phase 3 in previously untreated locally advanced or metastatic urothelial carcinoma
January 7, 2020Manufacturing and Production, Research and Development Bavencio, Merck KGaA, Pfizer, pharma
Bavencio (avelumab), the anti-programmed death ligand-1 (PD-L1) antibody co-developed by Pfizer and Merck KGaA’s biopharma unit EMD Serono, has been …
Bittersweet Phase 3 Keytruda data hits one of two goals in extensive stage small cell lung cancer
January 7, 2020Manufacturing and Production, Research and Development MSD, keytruda
MSD has lifted the curtain on new Phase 3 data on the efficacy of its blockbuster immunotherapy Keytruda, in combination …
Teva to settle bribery lawsuit with $54 million payout
January 7, 2020Manufacturing and Production, Sales and Marketing Teva, bribery, pharma
Israeli drug firm Teva has agreed to settle an ongoing lawsuit levying allegations of the company’s bribery of doctors, it …
Merck, Novartis and Allergan to raise US drug prices, following most of drug industry
January 6, 2020Manufacturing and Production Allgeran, Big Pharma, Merck, Novartis, drug, drug prices
Following most of the large pharmaceutical companies, Merck, Novartis and Allergan have chosen to raise their drug prices. Novartis is …
MHRA expands approval of Dysport for symptomatic treatment of focal spasticity of the upper limbs in paediatric cerebral palsy
January 6, 2020Sales and Marketing Dysport, MHRA, ipsen, pharma
Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare …
FDA gives a priority review for key heart failure drug Farxiga
January 6, 2020Sales and Marketing AstraZeneca, Heart Failures, farxiga
The FDA has accepted a New Drug Application (sNDA) and has granted a priority review for AstraZeneca’s drug Farxiga (dapagliflozin) …
Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out
January 6, 2020Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia
A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …
Incyte’s drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease
January 6, 2020Research and Development, Sales and Marketing Incyte, pharma, trial failure
Drugmaker Incyte has made it known that its selective JAK1 inhibitor therapy itacitinib fell short at Phase 3 in the …
AstraZeneca’s drug Lokelma approved in China
January 6, 2020Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
Novo Nordisk to offer US patient’s in immediate need free insulin
January 3, 2020Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes
Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
